Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 18.39B | 17.95B | 17.29B | 17.32B | 16.01B | 16.46B |
Gross Profit | 3.07B | 3.07B | 2.98B | 3.04B | 2.67B | 2.54B |
EBITDA | 1.11B | 1.26B | 1.23B | 1.28B | 482.79M | 938.78M |
Net Income | 297.58M | 363.26M | 365.90M | 421.56M | -401.30M | 11.28M |
Balance Sheet | ||||||
Total Assets | 13.57B | 13.01B | 12.42B | 12.71B | 12.38B | 11.95B |
Cash, Cash Equivalents and Short-Term Investments | 4.32B | 4.28B | 4.13B | 4.60B | 3.61B | 3.62B |
Total Debt | 7.27B | 6.29B | 6.06B | 6.38B | 6.53B | 5.44B |
Total Liabilities | 11.71B | 10.27B | 10.12B | 10.64B | 10.76B | 9.71B |
Stockholders Equity | 1.82B | 2.70B | 2.27B | 2.05B | 1.61B | 2.23B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 268.98M | 387.76M | 1.16B | 7.29M | 326.00M |
Operating Cash Flow | 0.00 | 657.91M | 855.57M | 1.61B | 526.40M | 711.00M |
Investing Cash Flow | 0.00 | -261.13M | -724.91M | -481.63M | -1.32B | -472.00M |
Financing Cash Flow | 0.00 | -226.57M | -609.36M | -276.78M | 788.51M | 186.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥3.45B | 11.75 | 2.38% | 2.85% | -5.28% | ||
72 Outperform | ¥4.16B | 8.90 | 2.54% | 9.04% | 6.37% | ||
72 Outperform | ¥24.43B | 12.99 | 4.04% | 0.69% | 1.90% | ||
66 Neutral | ¥29.93B | 70.42 | 2.48% | 6.29% | -54.28% | ||
65 Neutral | $26.88B | 15.20 | -4.27% | 3.19% | 1.02% | 1.89% | |
63 Neutral | ¥18.74B | 16.12 | 3.48% | 10.85% | 123.10% |